Free Trial
→ New “Trump” currency proposed in DC (From Paradigm Press) (Ad) Buy CHRO Stock  Free CHRO Stock Alerts

Chromocell Therapeutics (CHRO) SEC Filings & 10K Form

Chromocell Therapeutics logo
$1.84 +0.59 (+46.61%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.88 +0.04 (+2.45%)
As of 04/17/2025 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Chromocell Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
04/17/2025
5:11 AM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2025
8:30 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2025
8:31 PM		Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
4:08 PM		Chromocell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2025
6:00 AM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
12:09 PM		Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
Form SCHEDULE 13G
01/15/2025
4:27 PM		Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
Form SCHEDULE 13G
12/19/2024
11:15 PM		Chromocell Therapeutics (Filer)
Form EFFECT
12/11/2024
3:06 PM		Chromocell Therapeutics (Filer)
Form POS AM
12/02/2024
11:15 PM		Chromocell Therapeutics (Filer)
Form EFFECT
11/22/2024
3:30 PM		Chromocell Therapeutics (Filer)
Form POS AM
11/21/2024
8:00 AM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:03 PM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
3:19 PM		Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:20 PM		Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:22 PM		Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:19 PM		Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
4:14 PM		Chromocell Therapeutics (Filer)
Form 424B3
11/13/2024
3:30 PM		Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:05 PM		3i, LP (Filed by)
Chromocell Therapeutics (Subject)
Form SC 13G/A
10/24/2024
7:30 AM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/26/2024
4:08 PM		Chromocell Therapeutics (Filer)
Form DEF 14A
09/16/2024
3:55 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
3:56 PM		Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
4:35 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
4:30 PM		Chromocell Therapeutics (Filer)
Form PRE 14A
08/13/2024
4:23 PM		Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
4:19 PM		Chromocell Therapeutics (Filer)
Form 424B3
08/13/2024
3:31 PM		Chromocell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
3:50 PM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2024
11:15 PM		Chromocell Therapeutics (Filer)
Form EFFECT
08/06/2024
3:49 PM		Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:06 AM		Chromocell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/29/2024
8:07 AM		Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:08 AM		Chromocell Therapeutics (Filer)
Form 424B3
07/29/2024
8:15 AM		Chromocell Therapeutics (Filer)
Form S-1
Registration statement under Securities Act of 1933  
07/02/2024
4:15 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 3/A
07/02/2024
4:17 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:05 PM		Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:06 PM		Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:07 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4/A
Trump and Musk fight back (Ad)

Is there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.

Click here to see why Jeff believes this is the biggest stock story of the year — and which companie
06/18/2024
7:00 PM		Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:01 PM		Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:02 PM		Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
7:03 PM		Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
3:21 PM		Chromocell Therapeutics (Filer)
Form 424B3
05/15/2024
3:15 PM		Chromocell Therapeutics (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:CHRO) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...
Golden Portfolio | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Read before the next tariff announcement
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored